Treace Medical Concepts, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 47.2M | 62.5M | 50.2M | 47.4M | 52.6M | 68.7M | 45.1M | 44.5M |
| Cost of Goods Sold | 9.8M | 12.1M | 10.5M | 9.6M | 10.7M | 13.2M | 9.0M | 8.8M |
| Gross Profit | 37.4M | 50.4M | 39.7M | 37.8M | 41.9M | 55.5M | 36.1M | 35.7M |
| R&D Expenses | 4.6M | 4.5M | 4.7M | 5.5M | 5.6M | 5.2M | 5.0M | 5.2M |
| Operating Expenses | 54.6M | 56.3M | 55.4M | 54.7M | 57.5M | 55.7M | 51.3M | 57.1M |
| Operating Income | -17.2M | -5.9M | -15.7M | -17.0M | -15.6M | -204K | -15.1M | -21.4M |
| Other Income / Gains | -794K | -3.5M | -612K | -424K | -340K | -297K | -226K | 176K |
| Net Income | -18.0M | -9.4M | -16.3M | -17.4M | -15.9M | -501K | -15.4M | -21.2M |
| EPS (Diluted) | -0.28 | -0.15 | -0.26 | -0.28 | -0.25 | -0.008 | -0.25 | -0.34 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.793 | 0.806 | 0.791 | 0.797 | 0.797 | 0.807 | 0.801 | 0.802 |
| General And Administrative Expenses | 16.2M | 14.5M | 16.3M | 16.1M | 15.8M | 13.6M | 13.5M | 14.2M |
| Selling And Marketing Expenses | 33.8M | 37.3M | 33.4M | 33.1M | 36.1M | 36.9M | 32.8M | 37.7M |
| Selling General And Administrative Expenses | 50.0M | 51.8M | 49.7M | 49.2M | 51.9M | 50.5M | 46.3M | 51.9M |
| Other Expenses | 0 | 0 | 1.0M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 64.4M | 68.4M | 65.9M | 64.4M | 68.2M | 68.9M | 60.2M | 65.8M |
| Interest Income | 501K | 527K | 634K | 775K | 841K | 899K | 1.1M | 1.4M |
| Interest Expense | 1.6M | 1.4M | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M |
| Depreciation And Amortization | 899K | 2.9M | 2.8M | 2.6M | 2.5M | 2.2M | 2.2M | 2.1M |
| Ebitda | -15.5M | -5.2M | -12.2M | -13.5M | -12.2M | 3.0M | -11.9M | -17.8M |
| Ebitdaratio | -0.328 | -0.083 | -0.242 | -0.285 | -0.231 | 0.044 | -0.264 | -0.40 |
| Operating Income Ratio | -0.364 | -0.095 | -0.312 | -0.358 | -0.296 | -0.003 | -0.336 | -0.481 |
| Income Before Tax | -18.0M | -9.4M | -16.3M | -17.4M | -15.9M | -501K | -15.4M | -21.2M |
| Income Before Tax Ratio | -0.381 | -0.15 | -0.324 | -0.367 | -0.303 | -0.007 | -0.341 | -0.477 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.381 | -0.15 | -0.324 | -0.367 | -0.303 | -0.007 | -0.341 | -0.477 |
| Epsdiluted | -0.28 | -0.15 | -0.26 | -0.28 | -0.25 | -0.008 | -0.25 | -0.34 |
| Weighted Average Shs Out | 64.6M | 63.9M | 63.5M | 63.0M | 62.7M | 62.3M | 62.2M | 62.1M |
| Weighted Average Shs Out Dil | 64.6M | 63.9M | 63.5M | 63.0M | 62.7M | 62.3M | 62.2M | 62.1M |